Compare Stocks → Your Next Portfolio Star: Revealing 2024's Top Stock Pick (From Darwin) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:ALNANASDAQ:BVXVNASDAQ:INMBNASDAQ:NTGN Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALNAAllena Pharmaceuticals$0.07$0.06▼$1.17$37K1.1315.69 million shs96,558 shsBVXVBiondVax Pharmaceuticals$1.36$1.25▼$11.80$2.54M2.37127,289 shs23,000 shsINMBINmune Bio$8.80+4.4%$11.74$6.50▼$14.74$158.66M1.9987,905 shs97,911 shsNTGNNeon Therapeutics$3.07$3.03$0.88▼$6.25$88.93M-0.81516,108 shsN/A10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALNAAllena Pharmaceuticals0.00%0.00%0.00%0.00%0.00%BVXVBiondVax Pharmaceuticals0.00%0.00%0.00%0.00%-30.26%INMBINmune Bio-7.87%-22.23%-23.50%-22.23%+4.07%NTGNNeon Therapeutics0.00%0.00%0.00%0.00%0.00%Special FREE offer on stock hotsheets (Ad)These sheets tell you the exact day you should consider buying a stock… And the exact day you should consider selling it… All based on TEN YEARS of historic data and trends. For example, like January 6th through the 12th with Apple… It’s gone up every single year for the last decade. Or like May 26th through June 11th with LULU… Again - it’s gone up every single year for the last decade. Then there’s July 1st through the 21st with Walmart… What happened to WMT?Click here and I’ll show youMarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationALNAAllena PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/ABVXVBiondVax PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/AINMBINmune Bio1.1201 of 5 stars3.50.00.00.03.31.70.0NTGNNeon TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALNAAllena PharmaceuticalsN/AN/AN/AN/ABVXVBiondVax PharmaceuticalsN/AN/AN/AN/AINMBINmune Bio3.00Buy$16.0081.82% UpsideNTGNNeon TherapeuticsN/AN/AN/AN/ACurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALNAAllena PharmaceuticalsN/AN/AN/AN/A$0.23 per shareN/ABVXVBiondVax PharmaceuticalsN/AN/AN/AN/A($3.81) per shareN/AINMBINmune Bio$160K991.65N/AN/A$2.07 per share4.25NTGNNeon TherapeuticsN/AN/AN/AN/A$0.50 per shareN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALNAAllena Pharmaceuticals-$48.66MN/A0.00N/AN/AN/A-287.46%-146.58%N/ABVXVBiondVax Pharmaceuticals-$5.80M-$2.55N/AN/AN/AN/A-346.36%-29.52%N/AINMBINmune Bio-$30.01M-$1.67N/A∞N/A-19,360.00%-64.11%-45.57%5/1/2024 (Estimated)NTGNNeon Therapeutics-$79.78M-$2.86N/AN/AN/AN/A-199.09%-137.14%N/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthALNAAllena PharmaceuticalsN/AN/AN/AN/AN/ABVXVBiondVax PharmaceuticalsN/AN/AN/AN/AN/AINMBINmune BioN/AN/AN/AN/AN/ANTGNNeon TherapeuticsN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioALNAAllena PharmaceuticalsN/A1.581.58BVXVBiondVax PharmaceuticalsN/A4.124.12INMBINmune BioN/A2.162.16NTGNNeon Therapeutics0.431.583.00OwnershipInstitutional OwnershipCompanyInstitutional OwnershipALNAAllena Pharmaceuticals7.33%BVXVBiondVax Pharmaceuticals11.83%INMBINmune Bio12.72%NTGNNeon Therapeutics54.71%Insider OwnershipCompanyInsider OwnershipALNAAllena Pharmaceuticals3.70%BVXVBiondVax Pharmaceuticals6.03%INMBINmune Bio36.10%NTGNNeon Therapeutics38.93%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableALNAAllena Pharmaceuticals35122.08 million117.57 millionNot OptionableBVXVBiondVax Pharmaceuticals331.87 million1.76 millionNot OptionableINMBINmune Bio1018.03 million11.52 millionOptionableNTGNNeon Therapeutics10228.97 millionN/ANot OptionableALNA, BVXV, NTGN, and INMB HeadlinesSourceHeadlineNeon Trap Defensekotaku.com - April 14 at 12:18 AMBCYC Bicycle Therapeutics plcseekingalpha.com - April 9 at 1:09 PMneon oscillatorhackaday.com - March 20 at 10:44 AMNTGN_old Historical Datainvesting.com - February 20 at 3:42 PM2000 Plymouth Neoncars.com - January 13 at 7:49 PMNBCO Neon Bloom, Inc.seekingalpha.com - December 22 at 4:41 AMKansas City Ferris wheel could be out-dazzled by what will soon lie below: Neon Alleykansascity.com - November 13 at 11:05 PMStarfield Neon shops and locations – every vendor in Neonvideogamer.com - November 4 at 2:31 PMA Nixie Clock With Neon Bulb Logichackaday.com - October 5 at 7:57 AMStarfield | Where To Get Neon (Ne)hardcoregamer.com - September 29 at 8:17 AMStarfield Neon City guide – everything you need to knowvideogamer.com - September 14 at 8:09 AMStarfield: All Shops in Neon Citytwinfinite.net - September 10 at 4:42 PMShadows in Neonign.com - September 9 at 12:52 AMStarfield Neon city guidepcgamesn.com - August 19 at 11:48 PMApex Legends Neon Network Collection Eventign.com - August 4 at 10:49 PMFab Five: Neon fashion finds to brighten up your summer wardrobevancouversun.com - August 1 at 12:37 AMNeon White physical edition for PS5, Switch launches September 15gematsu.com - July 21 at 10:14 AMFast-paced platformer 'Neon White' is coming to Xboxengadget.com - June 22 at 9:32 AMAriana Madix Stuns in Neon Pantsuit Before Bombshell Scandoval Interviewaol.com - June 10 at 8:17 AMneon signhackaday.com - May 21 at 5:30 PMJessica Simpson Has Strong AF Abs And Toned Legs In A Neon SKIMS Bikini In An IG Photowomenshealthmag.com - May 7 at 10:17 AMEverything New In Fortnite Chapter 4 Season 2: Neon Lights, Katana Fights, And Moregamespot.com - April 12 at 6:19 PMMacbeth review – neon-tinted remix plays like a cinematic thrillertheguardian.com - March 1 at 10:35 PMLea Michele Rocks Neon One-Piece Swimsuit To Do Yoga While Paddleboarding: Photoshollywoodlife.com - March 1 at 10:35 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsAllena PharmaceuticalsNASDAQ:ALNAAllena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. Its lead product candidate is ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and gout in the setting of advanced chronic kidney disease. The company was incorporated in 2011 and is headquartered in Newton, Massachusetts.BiondVax PharmaceuticalsNASDAQ:BVXVBiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases, and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel.INmune BioNASDAQ:INMBINmune Bio, Inc., a clinical-stage immunology company, focuses on reprogramming the patient's innate immune system to treat cancer and neurodegenerative diseases. It intends to develop and commercialize product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. The company's development programs include INKmune, which focuses on treating women with relapse refractory ovarian carcinoma solid tumor and patients with high-risk myelodysplastic syndrome; INB03 to treat patients with cancers that express MUC4, a mucinous polyglucan on the surface of some epithelial cancer cells that appears to predict resistant to immunotherapy, including women with MUC4 expressing HER2+ breast cancer and other MUC4 resistant cancers; and XPro1595 for the treatment of Alzheimer's disease and Treatment Resistant Depression. It has license agreements with Xencor, Inc.; Immune Ventures, LLC; and University of Pittsburg. The company was incorporated in 2015 and is headquartered in Boca Raton, Florida.Neon TherapeuticsNASDAQ:NTGNNeon Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in developing neoantigen-targeted therapies for cancers in the United States. It is developing NEO-PV-01, a neoantigen vaccine that is in Phase Ib clinical trial in combination with nivolumab for the treatment of metastatic melanoma, non-small cell lung cancer, and bladder cancer; NEO-PTC-01, a neoantigen T cell therapy for the treatment of solid tumors; and NEO-SV-01, a neoantigen vaccine for the treatment of estrogen-receptor-positive breast cancer. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.